The effectiveness of platelet-rich plasma (PRP) injections for osteoarthritis (OA) is still controversial. Previous research supports the use of intra-articular PRP injections to promote a favorable environment for joint tissue healing and to delay the progression of OA. The purpose of this review is to investigate the effectiveness of PRP in the management of hip osteoarthritis (HOA). Five electronic databases were searched from inception to May 2019: Medline (via PubMed), SportDiscus via EBSCO, ProQuest Health & Medical Complete, CINAHL, and Cochrane. Risk of bias was assessed with the Cochrane risk of bias tool. The GRADE method was used to assess the level of evidence for the studies included in this review. Clinical trials evaluate PRP injections among adult patients diagnosed with HOA according to the American College of Rheumatology criteria. At least one outcome measure for pain or function must have been reported. A total of 4 trials (334 participants, 340 hips) were included, all marked as “moderate risk of bias”. Pain and function were assessed throughout the studies with visual analogue scale (VAS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), and Harris Hip Score (HHS) tools. Intra-articular PRP injections were more effective at stages earlier than 3 months for both treatment groups with the exception of WOMAC score in one study. The superiority of PRP against comparative treatments was only reported in one study; longer-term evaluations from 4 to 12 months showed diverse results, with only one study reporting significantly better results for PRP. PRP may be beneficial and safe for patients with HOA at mid-term follow-up. However, its superiority over other procedures such as hyaluronic acid remains unclear. Further researches with high-quality designs and larger samples become imperative.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Buckwalter JA, Martin JA (2006) Osteoarthritis. Adv Drug Deliv Rev 58:150–167. https://doi.org/10.1016/j.addr.2006.01.006
Murphy L, Helmick CG (2012) The impact of osteoarthritis in the United States: a population-health perspective. Am J Nurs 112:S13–S19. https://doi.org/10.1097/01.NAJ.0000412646.80054.21
Murray CJL, Lopez AD, Organization WH, Bank W, Health HS of P (1996) The Global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020: summary. World Health Organization
Murphy L, Helmick CG (2012) Preventing and Managing OA 112:7
Peat G, McCarney R, Croft P (2001) Knee pain and osteoarthritis in older adults: a review of community burden and current use of primary health care. Ann Rheum Dis 60:91–97. https://doi.org/10.1136/ard.60.2.91
Dawson J, Linsell L, Zondervan K, Rose P, Randall T, Carr A, Fitzpatrick R (2004) Epidemiology of hip and knee pain and its impact on overall health status in older adults. Rheumatology (Oxford) 43:497–504. https://doi.org/10.1093/rheumatology/keh086
Zhang W, Doherty M (2006) EULAR recommendations for knee and hip osteoarthritis: a critique of the methodology. Br J Sports Med 40:664–669. https://doi.org/10.1136/bjsm.2004.016840
Wang X, Hunter D, Xu J, Ding C (2015) Metabolic triggered inflammation in osteoarthritis. Osteoarthr Cartil 23:22–30. https://doi.org/10.1016/j.joca.2014.10.002
Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, Towheed T, Welch V, Wells G, Tugwell P, American College of Rheumatology (2012) American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res 64:465–474. https://doi.org/10.1002/acr.21596
Bruyere O, Reginster J-Y (2007) Glucosamine and chondroitin sulfate as therapeutic agents for knee and hip osteoarthritis. Drugs Aging 24:573–580. https://doi.org/10.2165/00002512-200724070-00005
Nelson AE, Allen KD, Golightly YM, Goode AP, Jordan JM (2014) A systematic review of recommendations and guidelines for the management of osteoarthritis: the chronic osteoarthritis management initiative of the U.S. bone and joint initiative. Semin Arthritis Rheum 43:701–712. https://doi.org/10.1016/j.semarthrit.2013.11.012
Ferrari M, Zia S, Valbonesi M, Henriquet F, Venere G, Spagnolo S, Grasso MA, Panzani I (1987) A new technique for hemodilution, preparation of autologous platelet-rich plasma and intraoperative blood salvage in cardiac surgery. Int J Artif Organs 10:47–50
Qi YY, Chen X, Jiang YZ, Cai HX, Wang LL, Song XH, Zou XH, Ouyang HW (2009) Local delivery of autologous platelet in collagen matrix simulated in situ articular cartilage repair. Cell Transplant 18:1161–1169. https://doi.org/10.3727/096368909X12483162197169
Sun Y, Feng Y, Zhang CQ, Chen SB, Cheng XG (2010) The regenerative effect of platelet-rich plasma on healing in large osteochondral defects. Int Orthop 34:589–597. https://doi.org/10.1007/s00264-009-0793-2
Pereira RC, Scaranari M, Benelli R, Strada P, Reis RL, Cancedda R, Gentili C (2013) Dual effect of platelet lysate on human articular cartilage: a maintenance of chondrogenic potential and a transient proinflammatory activity followed by an inflammation resolution. Tissue Eng A 19:1476–1488. https://doi.org/10.1089/ten.TEA.2012.0225
Wu C-C, Chen W-H, Zao B, Lai P-L, Lin T-C, Lo H-Y, Shieh YH, Wu CH, Deng WP (2011) Regenerative potentials of platelet-rich plasma enhanced by collagen in retrieving pro-inflammatory cytokine-inhibited chondrogenesis. Biomaterials 32:5847–5854. https://doi.org/10.1016/j.biomaterials.2011.05.002
Akeda K, An HS, Okuma M, Attawia M, Miyamoto K, Thonar EJ-MA, Lenz ME, Sah RL, Masuda K (2006) Platelet-rich plasma stimulates porcine articular chondrocyte proliferation and matrix biosynthesis. Osteoarthr Cartil 14:1272–1280. https://doi.org/10.1016/j.joca.2006.05.008
Qureshi AH, Chaoji V, Maiguel D, Faridi MH, Barth CJ, Salem SM, Singhal M, Stoub D, Krastins B, Ogihara M, Zaki MJ, Gupta V (2009) Proteomic and phospho-proteomic profile of human platelets in basal, resting state: insights into integrin signaling. PLoS One 4:e7627. https://doi.org/10.1371/journal.pone.0007627
Pietrzak WS, Eppley BL (2005) Platelet rich plasma: biology and new technology. J Craniofac Surg 16:1043–1054
Stiles CD (1983) The molecular biology of platelet-derived growth factor. Cell 33:653–655
Zhu Y, Yuan M, Meng HY, Wang AY, Guo QY, Wang Y, Peng J (2013) Basic science and clinical application of platelet-rich plasma for cartilage defects and osteoarthritis: a review. Osteoarthr Cartil 21:1627–1637. https://doi.org/10.1016/j.joca.2013.07.017
Di Matteo B, Filardo G, Kon E, Marcacci M (2014) Platelet-rich plasma: evidence for the treatment of patellar and Achilles tendinopathy-a systematic review. Musculoskelet Surg 99:1–9. https://doi.org/10.1007/s12306-014-0340-1
Figueroa D, Figueroa F, Calvo R, Vaisman A, Ahumada X, Arellano S (2015) Platelet-rich plasma use in anterior cruciate ligament surgery: systematic review of the literature. Arthroscopy 31:981–988. https://doi.org/10.1016/j.arthro.2014.11.022
Mostafaei S, Norooznezhad F, Mohammadi S, Norooznezhad AH (2017) Effectiveness of platelet-rich plasma therapy in wound healing of pilonidal sinus surgery: a comprehensive systematic review and meta-analysis. Wound Repair Regen 25:1002–1007. https://doi.org/10.1111/wrr.12597
Chen JX, Justicz N, Lee LN (2018) Platelet-rich plasma for the treatment of androgenic alopecia: a systematic review. Facial Plast Surg 34:631–640. https://doi.org/10.1055/s-0038-1660845
Bousnaki M, Bakopoulou A, Koidis P (2018) Platelet-rich plasma for the therapeutic management of temporomandibular joint disorders: a systematic review. Int J Oral Maxillofac Surg 47:188–198. https://doi.org/10.1016/j.ijom.2017.09.014
Bennell KL, Hunter DJ, Paterson KL (2017) Platelet-rich plasma for the management of hip and knee osteoarthritis. Curr Rheumatol Rep 19:24. https://doi.org/10.1007/s11926-017-0652-x
Tietze DC, Geissler K, Borchers J (2014) The effects of platelet-rich plasma in the treatment of large-joint osteoarthritis: a systematic review. Phys Sportsmed 42:27–37. https://doi.org/10.3810/psm.2014.05.2055
Dold AP, Zywiel MG, Taylor DW, Dwyer T, Theodoropoulos J (2014) Platelet-rich plasma in the management of articular cartilage pathology: a systematic review. Clin J Sport Med 24:31–43. https://doi.org/10.1097/01.jsm.0000432855.85143.e5
Ye Y, Zhou X, Mao S, Zhang J, Lin B (2018) Platelet rich plasma versus hyaluronic acid in patients with hip osteoarthritis: a meta-analysis of randomized controlled trials. Int J Surg 53:279–287. https://doi.org/10.1016/j.ijsu.2018.03.078
Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD et al (2011) The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343:d5928. https://doi.org/10.1136/bmj.d5928
Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097. https://doi.org/10.1371/journal.pmed.1000097
N.d. https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=10210 (accessed Jun 8, 2019)
Altman R, Alarcón G, Appelrouth D, Bloch D, Borenstein D, Brandt K, Brown C, Cooke TD, Daniel W, Feldman D, Greenwald R, Hochberg M, Howell D, Ike R, Kapila P, Kaplan D, Koopman W, Marino C, McDonald E, McShane DJ, Medsger T, Michel B, Murphy WA, Osial T, Ramsey-Goldman R, Rothschild B, Wolfe F (1991) The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 34:505–514
DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188
Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schünemann HJ, GRADE Working Group (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336:924–926. https://doi.org/10.1136/bmj.39489.470347.AD
Battaglia M, Guaraldi F, Vannini F, Rossi G, Timoncini A, Buda R, Giannini S (2013) Efficacy of ultrasound-guided intra-articular injections of platelet-rich plasma versus hyaluronic acid for hip osteoarthritis. Orthopedics 36:e1501–e1508
Dallari D, Stagni C, Rani N, Sabbioni G, Pelotti P, Torricelli P, Tschon M, Giavaresi G (2016) Ultrasound-guided injection of platelet-rich plasma and hyaluronic acid, separately and in combination, for hip osteoarthritis: a randomized controlled study. Am J Sports Med 44:664–671. https://doi.org/10.1177/0363546515620383
Di Sante L, Villani C, Santilli V, Valeo M, Bologna E, Imparato L et al (2016) Intra-articular hyaluronic acid vs platelet-rich plasma in the treatment of hip osteoarthritis. Med Ultrason 18:463–468. https://doi.org/10.11152/mu-874
Doria C, Mosele GR, Caggiari G, Puddu L, Ciurlia E (2017) Treatment of early hip osteoarthritis: ultrasound-guided platelet rich plasma versus hyaluronic acid injections in a randomized clinical trial. Joints 5:152–155. https://doi.org/10.1055/s-0037-1605584
Lawson B, Putnam W, Nicol K, Archibald G, Mackillop J, Conter H, Frail D (2004) Managing osteoarthritis. Medication use among seniors in the community. Can Fam Physician 50:1664–1670
(2005) Ottawa panel evidence-based clinical practice guidelines for therapeutic exercises and manual therapy in the management of osteoarthritis. Phys Ther 85:907–971
Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, Dougados M, Hochberg M, Hunter DJ, Kwoh K, Lohmander LS, Tugwell P (2008) OARSI recommendations for the management of hip and knee osteoarthritis, part II: OARSI evidence-based, expert consensus guidelines. Osteoarthr Cartil 16:137–162. https://doi.org/10.1016/j.joca.2007.12.013
Chang K-V, Hung C-Y, Aliwarga F, Wang T-G, Han D-S, Chen W-S (2014) Comparative effectiveness of platelet-rich plasma injections for treating knee joint cartilage degenerative pathology: a systematic review and meta-analysis. Arch Phys Med Rehabil 95:562–575. https://doi.org/10.1016/j.apmr.2013.11.006
Wehling P, Evans C, Wehling J, Maixner W (2017) Effectiveness of intra-articular therapies in osteoarthritis: a literature review. Ther Adv Musculoskelet Dis 9:183–196. https://doi.org/10.1177/1759720X17712695
The authors would like to acknowledge Patricia Alvarez-Juarez for her valuable contribution at the initial stages of this study.
Ethics approval and consent to participate
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Medina-Porqueres, I., Ortega-Castillo, M. & Muriel-Garcia, A. Effectiveness of platelet-rich plasma in the management of hip osteoarthritis: a systematic review and meta-analysis. Clin Rheumatol 40, 53–64 (2021). https://doi.org/10.1007/s10067-020-05241-x
- Growth factors
- Platelet-rich plasma